- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
International Journal of Endocrinology
Volume 2013 (2013), Article ID 428542, 4 pages
Hepatic Steatosis, Carbohydrate Intake, and Food Quotient in Patients with NAFLD
1Pôle Hépatogastroentérologie, Endocrinologie et Nutrition, CHU de Bordeaux, Avenue de Magellan, 33600 Pessac, France
2Service de Pathologie, CHU de Bordeaux, France
3INSERM, ISPED, Centre INSERM U897-Epidemiologie-Biostatistique, 33000 Bordeaux, France
Received 11 January 2013; Accepted 12 April 2013
Academic Editor: Kaori Minehira
Copyright © 2013 Concepcion Gonzalez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. G. Fan, J. Zhu, X. J. Li et al., “Prevalence of and risk factors for fatty liver in a general population of Shanghai, China,” Journal of Hepatology, vol. 43, no. 3, pp. 508–514, 2005.
- J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004.
- V. de Lédinghen, V. Ratziu, X. Causse et al., “Diagnostic and predictive factors of significant liver fibrosis and minimal lesions in patients with persistent unexplained elevated transaminases. A prospective multicenter study,” Journal of Hepatology, vol. 45, no. 4, pp. 592–602, 2006.
- V. Paradis, S. Zalisnski, E. Chelbi et al., “Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liverfibrosis: a pathological analysis,” Hepatology, vol. 49, no. 3, pp. 851–859, 2009.
- Y. C. Lin, H. M. Lo, and J. D. Chen, “Sonographic fatty liver, overweight and ischemic heart disease,” World Journal of Gastroenterology, vol. 11, no. 31, pp. 4838–4842, 2005.
- B. A. Neuschwander-Tetri, “Lifestyle modification as theprimary treatment of NASH,” Clinics in Liver Disease, vol. 13, no. 4, pp. 649–665, 2009.
- V. Ratziu, S. Bellentani, H. Cortez-Pinto, C. Day, and G. Marchesini, “A position statement on NAFLD/NASH based on the EASL 2009 special conference,” Journal of hepatology, vol. 53, no. 2, pp. 372–384, 2010.
- K. Yasutake, M. Kohjima, M. Nakashima, K. Kotoh, M. Nakamuta, and M. Enjoji, “Nutrition therapy for liver diseases based on the status of nutritional intake,” Gastroenterology Research and Practice, vol. 2012, Article ID 859697, 8 pages, 2012.
- C. Finelli and G. Tarantino, “Is there any consensus as to what diet or lifestyle approach is the right one for NAFLD patients?” Journal of Gastrointestinal and Liver Diseases, vol. 21, pp. 293–302, 2012.
- K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, “Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343–1351, 2005.
- K. R. Westerterp, M. A. Crawford, E. Ravussin, and M. Katan, “Food quotient, respiratory quotient, and energy balance,” American Journal of Clinical Nutrition, vol. 57, no. 5, pp. S759–S765, 1993.
- M. K. Hellerstein, “No common energy currency: de novo lipogenesis as the road less traveled,” American Journal of Clinical Nutrition, vol. 74, no. 6, pp. 707–708, 2001.
- R. M. McDevitt, S. J. Bott, M. Harding, W. A. Coward, L. J. Bluck, and A. M. Prentice, “De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women,” American Journal of Clinical Nutrition, vol. 74, no. 6, pp. 737–746, 2001.
- F. Diraison, P. H. Moulin, and M. Beylot, “Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease,” Diabetes and Metabolism, vol. 29, no. 5, pp. 478–485, 2003.
- D. Faeh, K. Minehira, J. M. Schwarz, R. Periasami, P. Seongsu, and L. Tappy, “Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men,” Diabetes, vol. 54, no. 7, pp. 1907–1913, 2005.
- J. D. Browning, J. A. Baker, T. Rogers, J. Davis, S. Satapati, and S. C. Burgess, “Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction,” American Journal of Clinical Nutrition, vol. 93, no. 5, pp. 1048–1052, 2011.
- K. Sevastianova, A. Santos, A. Kotronen, et al., “Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans,” American Journal of Clinical Nutrition, vol. 96, pp. 727–734, 2012.
- M. R. Teli, O. F. W. James, A. D. Burt, M. K. Bennett, and C. P. Day, “The natural history of nonalcoholic fatty liver: a follow-up study,” Hepatology, vol. 22, no. 6, pp. 1714–1719, 1995.
- K. Promrat, D. E. Kleiner, H. M. Niemeier et al., “Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis (NASH),” Hepatology, vol. 51, no. 1, pp. 121–129, 2010.
- G. Ricci, E. Canducci, V. Pasini et al., “Nutrient intake in Italian obese patients: relationships with insulin resistance and markers of non-alcoholic fatty liver disease,” Nutrition, vol. 27, no. 6, pp. 672–676, 2011.
- M. F. Abdelmalek, A. Suzuki, C. Guy et al., “Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease,” Hepatology, vol. 51, no. 6, pp. 1961–1971, 2010.
- I. Shai, D. Schwarzfuchs, Y. Henkin, et al., “Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet,” New England Journal of Medicine, vol. 35, pp. 229–241, 2008.
- A. M. Zivkovic, J. B. German, and A. J. Sanyal, “Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease,” American Journal of Clinical Nutrition, vol. 86, no. 2, pp. 285–300, 2007.